| Randal W Swenson, MD | |
|
4000 S 700 E, Ste 10, Slc, UT 84107-2180 | |
| (801) 268-4141 | |
| (801) 268-4141 |
| Full Name | Randal W Swenson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 45 Years |
| Location | 4000 S 700 E, Slc, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578522959 | NPI | - | NPPES |
| 870354540001 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 172807-1205 (Utah) | Primary |
| 207Y00000X | Otolaryngology | 172807-1205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent Professional Association Services | 8921053349 | 15 |
News Archive
DNA damage can lead to gene inactivation or deregulation and cause various diseases such as cancer; however, many DNA repair mechanisms allow cells to survive against such damage. A study lead by Antoine Simoneau of the laboratory of Dr. Hugo Wurtele, a researcher in immunology-oncology at the Maisonneuve-Rosemont Hospital (CIUSS de l'Est-de-l'Île-de-Montréal) and professor at the Faculty of Medicine, University of Montreal, and recently published in the prestigious journal Nucleic Acids Research, provides valuable information about certain mechanisms governing DNA repair.
The genetic architecture of a debilitating and potentially fatal vascular disease has for the first time been detailed in its entirety, providing clinicians with the comprehensive data needed to improve diagnosis and deliver more personalised patient care.
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published in Brain.
Genoptix, Inc., a specialized laboratory service provider, and HistoRx, Inc. (privately held), a diagnostics company, today announced a multi-year licensing agreement for AQUA® technology and several diagnostic assays based on it.
› Verified 5 days ago
| Entity Name | Ent Professional Association Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801857271 PECOS PAC ID: 8921053349 Enrollment ID: O20050318000500 |
News Archive
DNA damage can lead to gene inactivation or deregulation and cause various diseases such as cancer; however, many DNA repair mechanisms allow cells to survive against such damage. A study lead by Antoine Simoneau of the laboratory of Dr. Hugo Wurtele, a researcher in immunology-oncology at the Maisonneuve-Rosemont Hospital (CIUSS de l'Est-de-l'Île-de-Montréal) and professor at the Faculty of Medicine, University of Montreal, and recently published in the prestigious journal Nucleic Acids Research, provides valuable information about certain mechanisms governing DNA repair.
The genetic architecture of a debilitating and potentially fatal vascular disease has for the first time been detailed in its entirety, providing clinicians with the comprehensive data needed to improve diagnosis and deliver more personalised patient care.
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published in Brain.
Genoptix, Inc., a specialized laboratory service provider, and HistoRx, Inc. (privately held), a diagnostics company, today announced a multi-year licensing agreement for AQUA® technology and several diagnostic assays based on it.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randal W Swenson, MD 4000 S 700 E, Ste 10, Slc, UT 84107-2180 Ph: (801) 268-4141 | Randal W Swenson, MD 4000 S 700 E, Ste 10, Slc, UT 84107-2180 Ph: (801) 268-4141 |
News Archive
DNA damage can lead to gene inactivation or deregulation and cause various diseases such as cancer; however, many DNA repair mechanisms allow cells to survive against such damage. A study lead by Antoine Simoneau of the laboratory of Dr. Hugo Wurtele, a researcher in immunology-oncology at the Maisonneuve-Rosemont Hospital (CIUSS de l'Est-de-l'Île-de-Montréal) and professor at the Faculty of Medicine, University of Montreal, and recently published in the prestigious journal Nucleic Acids Research, provides valuable information about certain mechanisms governing DNA repair.
The genetic architecture of a debilitating and potentially fatal vascular disease has for the first time been detailed in its entirety, providing clinicians with the comprehensive data needed to improve diagnosis and deliver more personalised patient care.
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published in Brain.
Genoptix, Inc., a specialized laboratory service provider, and HistoRx, Inc. (privately held), a diagnostics company, today announced a multi-year licensing agreement for AQUA® technology and several diagnostic assays based on it.
› Verified 5 days ago
David K Palmer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4000 S 700 E, Ste 10, Slc, UT 84107 Phone: 801-268-4141 Fax: 801-261-8609 | |
Dr. John E Butler, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4000 S 700 E, Ste 10, Slc, UT 84107 Phone: 801-268-4141 Fax: 801-261-8609 | |
Jerry W Sonkens, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4000 S 700 E, Ste 10, Slc, UT 84107 Phone: 801-268-4141 Fax: 801-261-8609 |